Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REDDS Capital is a private early-stage venture capital firm based in Irvine, California that partners with founders to build disruptive technology companies. The firm describes its strategy as an "Open Innovation Venture Capital Model," in which it connects portfolio companies with large corporate partners to accelerate commercialization, financing, and potential acquisition opportunities. REDDS Capital operates across North America, Israel, Asia, and the EU and appears to invest broadly across technology sectors rather than operating as a drug-development or healthcare company. Available public information indicates the firm is active, private, and focused on venture investing, mentoring, global business development, and strategic support for startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REDDS Capital.